Species-Specific Antimicrobial Resistance Among Bacterial Isolates from Blood Cultures in ICU and Non-ICU Settings at a Tertiary Hospital in Western Romania, 2024–2025

Background/Objectives: Antimicrobial resistance among bloodstream pathogens compromises empirical treatment and infection prevention, but contemporary hospital-level data from western Romania remain limited. We characterized pathogen distribution and resistance, compared resistance by year and intensive care unit (ICU) location, and identified factors associated with meropenem resistance. Methods: This retrospective, single-center study included bacterial isolates recovered from blood cultures at a tertiary hospital in Timișoara, Romania, during 2024–2025. The first isolate of each species per patient and calendar year was retained. Quantitative susceptibility results were reinterpreted using the European Committee on Antimicrobial Susceptibility Testing (EUCAST) version 15.0. Species-specific, annual, and ICU/non-ICU comparisons and multivariable logistic regression were performed. Results: The cohort included 1055 isolates from 1017 patients. Klebsiella pneumoniae was most frequent (32.1%), followed by Escherichia coli (18.7%), Staphylococcus aureus (17.0%), and Acinetobacter baumannii (12.4%). K. pneumoniae resistance was 68.0% to meropenem, 75.1% to ceftazidime, and 73.7% to ciprofloxacin; A. baumannii resistance was 89.1% to meropenem and 91.5% to amikacin. After Benjamini–Hochberg correction, the only statistically significant annual difference was an increase in the proportion of A. baumannii isolates categorized as colistin-resistant by VITEK 2, from 6.0% to 41.9% (adjusted p < 0.001); this finding was not confirmed by reference broth microdilution. Conclusions: Resistance was high, particularly in K. pneumoniae and A. baumannii, with an ICU-associated gradient. ICU-focused surveillance and antimicrobial stewardship are warranted. The observed increase in A. baumannii colistin resistance requires confirmation by reference broth microdilution.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2026-11-17
DOI
https://doi.org/10.3390/jcm15229021
Primary Topic
Antibiotic Resistance in Bacteria
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Species-Specific Antimicrobial Resistance Among Bacterial Isolates from Blood Cultures in ICU and Non-ICU Settings at a Tertiary Hospital in Western Romania, 2024–2025

Ciprian Gîndac, Adela Voinescu, Silvia Ioana Musuroi, Monica Licker et al.
Journal of Clinical Medicine
Antibiotic Resistance in Bacteria
article

Species-Specific Antimicrobial Resistance Among Bacterial Isolates from Blood Cultures in ICU and Non-ICU Settings at a Tertiary Hospital in Western Romania, 2024–2025

Ciprian Gîndac, Adela Voinescu, Silvia Ioana Musuroi, Monica Licker, Dorel Săndesc, Corina Muşuroi, Dorina Dugăeșescu, Delia Doris Muntean, Andrei Cosnita, Andrei Dăescu, Lenuta Varvari Timis
article en

Abstract

Background/Objectives: Antimicrobial resistance among bloodstream pathogens compromises empirical treatment and infection prevention, but contemporary hospital-level data from western Romania remain limited. We characterized pathogen distribution and resistance, compared resistance by year and intensive care unit (ICU) location, and identified factors associated with meropenem resistance. Methods: This retrospective, single-center study included bacterial isolates recovered from blood cultures at a tertiary hospital in Timișoara, Romania, during 2024–2025. The first isolate of each species per patient and calendar year was retained. Quantitative susceptibility results were reinterpreted using the European Committee on Antimicrobial Susceptibility Testing (EUCAST) version 15.0. Species-specific, annual, and ICU/non-ICU comparisons and multivariable logistic regression were performed. Results: The cohort included 1055 isolates from 1017 patients. Klebsiella pneumoniae was most frequent (32.1%), followed by Escherichia coli (18.7%), Staphylococcus aureus (17.0%), and Acinetobacter baumannii (12.4%). K. pneumoniae resistance was 68.0% to meropenem, 75.1% to ceftazidime, and 73.7% to ciprofloxacin; A. baumannii resistance was 89.1% to meropenem and 91.5% to amikacin. After Benjamini–Hochberg correction, the only statistically significant annual difference was an increase in the proportion of A. baumannii isolates categorized as colistin-resistant by VITEK 2, from 6.0% to 41.9% (adjusted p < 0.001); this finding was not confirmed by reference broth microdilution. Conclusions: Resistance was high, particularly in K. pneumoniae and A. baumannii, with an ICU-associated gradient. ICU-focused surveillance and antimicrobial stewardship are warranted. The observed increase in A. baumannii colistin resistance requires confirmation by reference broth microdilution.

Journal of Clinical MedicineVol. 15(22)
Spitalul Clinic Judeţean de Urgenţă "Pius Brînzeu" Timişoara (RO), Victor Babeș University of Medicine and Pharmacy Timișoara (RO)
Antibiotic Resistance in Bacteria
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon